Laser procedure could offer new hope for pseudoexfoliation glaucoma patients

NCT ID NCT07401290

Not yet recruiting Disease control Sponsor: Vance Thompson Vision Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a non-invasive laser procedure called direct selective laser trabeculoplasty (DSLT) in 40 adults with pseudoexfoliation glaucoma. The goal is to see if the laser can safely lower eye pressure by at least 20% at 6 and 12 months. Participants will have their eye pressure measured after stopping any glaucoma medications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Direct selective laser trabeculoplasty (DSLT) - a non-invasive laser procedure to improve fluid drainage in the eye
What this could lead to: If successful, this laser treatment could offer a safe, non-drug option to control eye pressure in people with pseudoexfoliation glaucoma.
What could go wrong: This is a small, early-stage study with only 40 participants and no comparison group. The results may not apply to all patients, and the procedure may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSEUDOEXFOLIATION GLAUCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

exfoliation syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PSEUDOEXFOLIATION GLAUCOMA

Contacts and locations

Locations

Vance Thompson Vision

Alexandria, Minnesota, 56308, United States
Vance Thompson Vision

Omaha, Nebraska, 68137, United States
Vance Thompson Vision

Fargo, North Dakota, 58078, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.